+44 (0)20 3910 4640 hello@symmetron.net
  • Twitter
  • Twitter
Symmetron
  • Services
  • Success stories
  • Therapeutic areas
  • Insights
  • The team
  • Careers
  • Contact
Select Page

When is a simple model enough? How to handle structural uncertainty in cost-effectiveness models.

by Sam Bryning | Oct 6, 2021 | Cost-effectiveness analysis, Market access

Sam Bryning, intern at Symmetron: ‘formally accounting for structural uncertainty in cost-effectiveness models makes research and decision making more robust’. Cost-effectiveness models in healthcare attempt to capture the main features of clinical...
  • November 2021
  • October 2021
  • August 2021
  • July 2021
  • Budget impact
  • Clinical trial
  • Cost-effectiveness analysis
  • Evidence generation
  • Evidence synthesis
  • Health economic modelling
  • Health outcomes
  • Healthcare
  • Market access
  • Medical affairs
  • NICE
  • Oncology
  • Services
  • Success stories
  • Therapeutic areas
  • Insights
  • The team
  • Careers
  • Contact
  • Privacy Policy
  • LinkedIn
  • Twitter
© 2021 Symmetron Limited